The biotechnology company Eikon Therapeutics has signed a lease with Alexandria Real Estate Equities, Inc. for its new East Coast base of operations located in the Alexandria Center for Life Science in New York City.

The 25,000 square foot mixed-use facility will allow Eikon to establish a clinical development arm, expand upon existing research functions, attract top talent on both U.S. coasts, and explore potential collaborations with entities on the East Coast.

Eikon’s chief medical officer, Roy Baynes, will lead the company’s East Coast site operations. “With this state-of-the-art facility, we gain access to the New York metropolitan area’s unmatched pool of talent, including physicians and scientists that have trained at some of the world’s most renowned universities, clinical research institutions and biopharmaceutical companies,” said Baynes.

Roger Perlmutter, CEO of Eikon Therapeutics, said, “Eikon is proud to join the community of life science companies based in the New York City region, and we are privileged to have Dr. Baynes to lead this expansion. Roy’s deep expertise in clinical development positions us to attract gifted physician-scientists to Eikon’s research enterprise.”

Eikon recently announced that it is also collaborating with Alexandria to develop the company’s new 285,000 square foot global headquarters in Millbrae, CA.